Annual ROE
12.68%
+2.65%+26.42%
31 December 2023
Summary:
Neurocrine Biosciences annual return on equity is currently 12.68%, with the most recent change of +2.65% (+26.42%) on 31 December 2023. During the last 3 years, it has fallen by -33.52% (-72.55%). NBIX annual ROE is now -86.60% below its all-time high of 94.61%, reached on 31 December 2011.NBIX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
16.29%
+0.85%+5.51%
30 September 2024
Summary:
Neurocrine Biosciences quarterly return on equity is currently 16.29%, with the most recent change of +0.85% (+5.51%) on 30 September 2024. Over the past year, it has increased by +5.43% (+50.00%). NBIX quarterly ROE is now -88.03% below its all-time high of 136.08%, reached on 30 September 2011.NBIX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | +50.0% |
| 3 y3 years | -72.5% | -57.8% |
| 5 y5 years | +156.2% | +270.2% |
NBIX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.5% | +76.8% | -57.8% | +1710.0% |
| 5 y | 5 years | -72.5% | +156.2% | -67.2% | +1710.0% |
| alltime | all time | -86.6% | +105.1% | -88.0% | +103.9% |
Neurocrine Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 16.29%(+5.5%) |
| June 2024 | - | 15.44%(-15.2%) |
| Mar 2024 | - | 18.20%(+38.2%) |
| Dec 2023 | 12.68%(+26.4%) | 13.17%(+21.3%) |
| Sept 2023 | - | 10.86%(+1.1%) |
| June 2023 | - | 10.74%(+160.0%) |
| Mar 2023 | - | 4.13%(-60.2%) |
| Dec 2022 | 10.03%(+39.9%) | 10.38%(+152.6%) |
| Sept 2022 | - | 4.11%(+356.7%) |
| June 2022 | - | 0.90%(-83.4%) |
| Mar 2022 | - | 5.41%(-23.6%) |
| Dec 2021 | 7.17%(-84.5%) | 7.08%(-81.7%) |
| Sept 2021 | - | 38.60%(+11.0%) |
| June 2021 | - | 34.76%(-19.3%) |
| Mar 2021 | - | 43.06%(-13.3%) |
| Dec 2020 | 46.20%(+597.9%) | 49.68%(+277.2%) |
| Sept 2020 | - | 13.17%(-58.5%) |
| June 2020 | - | 31.74%(+0.9%) |
| Mar 2020 | - | 31.47%(+339.5%) |
| Dec 2019 | 6.62%(+33.7%) | 7.16%(+62.7%) |
| Sept 2019 | - | 4.40%(+7.3%) |
| June 2019 | - | 4.10%(-143.5%) |
| Mar 2019 | - | -9.42%(-282.2%) |
| Dec 2018 | 4.95%(-111.9%) | 5.17%(+98.8%) |
| Sept 2018 | - | 2.60%(-118.1%) |
| June 2018 | - | -14.38%(-54.5%) |
| Mar 2018 | - | -31.62%(-27.8%) |
| Dec 2017 | -41.50%(+8.7%) | -43.81%(-27.5%) |
| Sept 2017 | - | -60.41%(-9.9%) |
| June 2017 | - | -67.03%(+14.4%) |
| Mar 2017 | - | -58.60%(+56.6%) |
| Dec 2016 | -38.17%(+35.9%) | -37.42%(+20.1%) |
| Sept 2016 | - | -31.17%(+7.8%) |
| June 2016 | - | -28.91%(+20.8%) |
| Mar 2016 | - | -23.93%(+9.4%) |
| Dec 2015 | -28.09%(-23.6%) | -21.88%(+1.4%) |
| Sept 2015 | - | -21.58%(+15.6%) |
| June 2015 | - | -18.66%(+4.8%) |
| Mar 2015 | - | -17.80%(-39.0%) |
| Dec 2014 | -36.79%(+9.7%) | -29.19%(+8.1%) |
| Sept 2014 | - | -27.01%(-0.0%) |
| June 2014 | - | -27.02%(-8.3%) |
| Mar 2014 | - | -29.48%(-12.4%) |
| Dec 2013 | -33.55%(-815.4%) | -33.64%(+83.5%) |
| Sept 2013 | - | -18.33%(+48.1%) |
| June 2013 | - | -12.38%(+193.4%) |
| Mar 2013 | - | -4.22%(-208.5%) |
| Dec 2012 | 4.69%(-95.0%) | 3.89%(-236.5%) |
| Sept 2012 | - | -2.85%(-107.9%) |
| June 2012 | - | 36.26%(-33.4%) |
| Mar 2012 | - | 54.48%(-46.1%) |
| Dec 2011 | 94.61%(-238.3%) | 101.15%(-25.7%) |
| Sept 2011 | - | 136.08%(+147.1%) |
| June 2011 | - | 55.07%(-29.9%) |
| Mar 2011 | - | 78.61%(+364.9%) |
| Dec 2010 | -68.40% | 16.91%(-121.3%) |
| Sept 2010 | - | -79.39%(-66.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -235.81%(-43.2%) |
| Mar 2010 | - | -414.95%(+11.0%) |
| Dec 2009 | -250.63%(+119.9%) | -373.84%(+32.9%) |
| Sept 2009 | - | -281.26%(+42.7%) |
| June 2009 | - | -197.15%(+34.8%) |
| Mar 2009 | - | -146.29%(+31.3%) |
| Dec 2008 | -113.99%(+19.2%) | -111.43%(-28.1%) |
| Sept 2008 | - | -154.95%(+27.4%) |
| June 2008 | - | -121.59%(+22.8%) |
| Mar 2008 | - | -99.04%(+18.4%) |
| Dec 2007 | -95.66%(+214.5%) | -83.65%(+157.4%) |
| Sept 2007 | - | -32.50%(-4.0%) |
| June 2007 | - | -33.87%(+6.2%) |
| Mar 2007 | - | -31.88%(+5.7%) |
| Dec 2006 | -30.42%(+437.5%) | -30.17%(-3.3%) |
| Sept 2006 | - | -31.19%(+133.3%) |
| June 2006 | - | -13.37%(+75.9%) |
| Mar 2006 | - | -7.60%(+32.4%) |
| Dec 2005 | -5.66%(-51.5%) | -5.74%(+18.8%) |
| Sept 2005 | - | -4.83%(-59.3%) |
| June 2005 | - | -11.88%(-8.2%) |
| Mar 2005 | - | -12.94%(+15.0%) |
| Dec 2004 | -11.66%(+18.6%) | -11.25%(+107.6%) |
| Sept 2004 | - | -5.42%(-34.4%) |
| June 2004 | - | -8.26%(-8.0%) |
| Mar 2004 | - | -8.98%(-15.3%) |
| Dec 2003 | -9.83%(-72.2%) | -10.60%(-62.0%) |
| Sept 2003 | - | -27.87%(-20.0%) |
| June 2003 | - | -34.82%(-4.0%) |
| Mar 2003 | - | -36.27%(+4.8%) |
| Dec 2002 | -35.36%(+126.8%) | -34.61%(+26.6%) |
| Sept 2002 | - | -27.34%(+34.3%) |
| June 2002 | - | -20.35%(+3.3%) |
| Mar 2002 | - | -19.70%(-2.3%) |
| Dec 2001 | -15.59%(-29.7%) | -20.16%(-12.8%) |
| Sept 2001 | - | -23.12%(-31.5%) |
| June 2001 | - | -33.76%(+13.8%) |
| Mar 2001 | - | -29.67%(+7.1%) |
| Dec 2000 | -22.19%(+11.2%) | -27.70%(-0.1%) |
| Sept 2000 | - | -27.73%(+14.1%) |
| June 2000 | - | -24.30%(-1.7%) |
| Mar 2000 | - | -24.73%(+5.7%) |
| Dec 1999 | -19.95%(-22.6%) | -23.40%(-19.7%) |
| Sept 1999 | - | -29.15%(+7.8%) |
| June 1999 | - | -27.05%(-10.4%) |
| Mar 1999 | - | -30.19%(+19.1%) |
| Dec 1998 | -25.77%(-494.0%) | -25.35%(+54.0%) |
| Sept 1998 | - | -16.46%(+56.6%) |
| June 1998 | - | -10.51%(+2665.8%) |
| Mar 1998 | - | -0.38%(-105.9%) |
| Dec 1997 | 6.54%(-19.3%) | 6.43%(-49.4%) |
| Sept 1997 | - | 12.70%(+11.4%) |
| June 1997 | - | 11.40%(-29.1%) |
| Mar 1997 | - | 16.08%(+59.2%) |
| Dec 1996 | 8.10% | 10.10%(+287.0%) |
| Sept 1996 | - | 2.61%(-32.7%) |
| June 1996 | - | 3.88% |
FAQ
- What is Neurocrine Biosciences annual return on equity?
- What is the all time high annual ROE for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual ROE year-on-year change?
- What is Neurocrine Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly ROE year-on-year change?
What is Neurocrine Biosciences annual return on equity?
The current annual ROE of NBIX is 12.68%
What is the all time high annual ROE for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual return on equity is 94.61%
What is Neurocrine Biosciences annual ROE year-on-year change?
Over the past year, NBIX annual return on equity has changed by +2.65% (+26.42%)
What is Neurocrine Biosciences quarterly return on equity?
The current quarterly ROE of NBIX is 16.29%
What is the all time high quarterly ROE for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly return on equity is 136.08%
What is Neurocrine Biosciences quarterly ROE year-on-year change?
Over the past year, NBIX quarterly return on equity has changed by +5.43% (+50.00%)